Literature DB >> 2907319

Two distinct HLA-DR3 haplotypes are associated with age related heterogeneity in type 1 (insulin-dependent) diabetes.

I Deschamps1, A Marcelli-Barge, J C Poirier, O Cohen-Haguenauer, H Abderrahim, D Cohen, H Lestradet, J Hors.   

Abstract

Heterogeneity between two haplotypes in linkage disequilibrium with DR3: B8, C4AQOB1,BfS,DR3 and B18,C4A3BQO,BfF1,DR3, with regard to age at onset of Type 1 (insulin-dependent) diabetes mellitus, was investigated in 325 unrelated French patients (146 males and 179 females, age at onset 1 month to 29 years) who were genotyped for HLA-A, B, C, DR and Bf and 225 of whom were typed for the C4A, B complement components. A subgroup of 82 patients and 75 control subjects were tested for DR beta and DQ beta DNA restriction fragment length polymorphism. The distribution according to age at onset and the mean ages at onset were compared between patients bearing B8, DR3 (n = 58), B18,DR3 (n = 62) or other DR3 haplotypes (Bx, DR3, n = 70), the haplotype segments C4AQOB1,DR3 (n = 41) or C4A3BQO,DR3 (n = 52) and the C4 null alleles C4AQO (N = 48) or C4BQO (n = 112) alone. The B8,DR3 haplotype, its smaller segment C4AQOB1,DR3 or C4AQO alone were associated with age at onset after 6 years (p less than 0.01, less than 0.08 and less than 0.02 respectively); on the other hand, the B18,DR3 haplotype, its segment C4A3BQO,DR3 or C4BQO alone were significantly more frequent in patients aged less than 6 years at onset (p less than 0.02, less than 0.01 and less than 0.01 respectively). Accordingly, the mean age of onset was significantly lower in the latter compared with the former patients (p less than 0.02, less than 0.02 and less than 0.01 respectively). No age-related variation was observed in BX,DR3 patients and their mean age of onset was intermediate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907319     DOI: 10.1007/BF00265374

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Juvenile diabetes mellitus: HLA-antigen frequencies dependent on the age of onset of the disease.

Authors:  G Schernthaner; H Ludwig; W R Mayr
Journal:  J Immunogenet       Date:  1976-04

Review 3.  Inherited complement deficiency states and SLE.

Authors:  R I Rynes
Journal:  Clin Rheum Dis       Date:  1982-04

4.  HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families.

Authors:  L Contu; I Deschamps; H Lestradet; J Hors; M Schmid; M Busson; A Benajam; A Marcelli-Barge; J Dausset
Journal:  Tissue Antigens       Date:  1982-08

5.  Genetic heterogeneity of diabetes and HLA.

Authors:  J Barbosa; F H Bach; S S Rich
Journal:  Clin Genet       Date:  1982-01       Impact factor: 4.438

6.  The complement system in type 1 (insulin-dependent) diabetes.

Authors:  J A Charlesworth; V Timmermans; J Golding; L V Campbell; P W Peake; B A Pussell; D Wakefield; N Howard
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

7.  Studies of the HLA system and insulin-dependent diabetes mellitus.

Authors:  M Christy; A Green; B Christau; H Kromann; J Nerup; P Platz; M Thomsen; L P Ryder; A Svejgaard
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

8.  HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population.

Authors:  A Svejgaard; B K Jakobsen; P Platz; L P Ryder; J Nerup; M Christy; K Borch-Johnsen; H H Parving; T Deckert; L Mølsted-Pedersen
Journal:  Tissue Antigens       Date:  1986-10

9.  Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes.

Authors:  A Marcelli-Barge; J C Poirier; M Schmid; I Deschamps; H Lestradet; P Prevost; J Hors
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

10.  Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus.

Authors:  H F Champsaur; G F Bottazzo; J Bertrams; R Assan; C Bach
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

View more
  4 in total

1.  Permanent neonatal diabetes mellitus: lack of diabetic complications after a 20-year follow up.

Authors:  H Dorchy
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients.

Authors:  I Deschamps; J Hors; F Clerget-Darpoux; E Gardais; J J Robert; A Marcelli-Berge; H Lestradet; J Dausset
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

Review 3.  Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus.

Authors:  E Thorsby; K S Rønningen
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

4.  Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.

Authors:  I Deschamps; C Boitard; J Hors; M Busson; A Marcelli-Barge; A Mogenet; J J Robert
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.